The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study-Reference-Cited by-同舟云学术

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study

Published:2023-11-14 Issue:1 Volume:41 Page:349-363
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Yang Jingyan,Chaudhry Basit I.,Yue Andrew T.,Roth Joshua A.,Kelton John M.,Shelbaya Ahmed,Tran Lisa,Li Meng^ORCID

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02703-x.pdf

Reference63 articles.

1. McClellan M, Thoumi A. Oncology payment reform to achieve real health care reform. J Oncol Pract. 2015;11(3):223–30. https://doi.org/10.1200/JOP.2015.004655.

2. de Souza J, de Lima LG. Medicare reimbursement changes and the practice of oncology: understanding of the past is a key to the future. J Oncol Pract. 2011;7(5):306–8. https://doi.org/10.1200/JOP.2010.000043.

3. Mariotto A, Enewold L, Zhao J, Zeruto C, Yabroff K. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1304–12. https://doi.org/10.1158/1055-9965.EPI-19-1534.

4. Wen L, Divers C, Lingohr-Smith M, Lin J, Ramsey S. Improving quality of care in oncology through healthcare payment reform. Am J Manag Care. 2018;24(3):e93–e98.

5. Goldman D, Lakdawalla D, Newcomer L. It’s time for value-based payment in oncology. Health Affairs Blog. 2015. https://doi.org/10.1377/hblog20150428.047344.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar in Cervical Cancer;Biosimilars for Cancer Treatment;2024